TAT-HuR-HNS3

£185.00 1mg

HuR-PARP1 interaction blocker.

TAT-HuR-HNS3 is a cell penetrating peptide derived from the human antigen R – nucleocytoplasmic shuttling sequence (HuR-HNS) domain. HuR, also known as embryonic lethal abnormal vision-like 1 (ELAVL1) is a well characterized RNA-binding protein that increases the stability of short lived mRNAs which encode proinflammatory mediators. HuR employs its HNS domain to interact with poly(ADP-ribose) polymerase 1 (PARP1), and intervention by TAT-HuR-HNS3 interrupts this interaction, resulting in lower poly-ADP-ribosylation and decreased cytoplasmic distribution of HuR. TAT-HuR-HNS3 also blocks HuR dimerization and promotes argonaute 2-based miRNA induced silencing complex binding. TAT-HuR-HNS3 lowers the mRNA stability of proinflammatory mediators in TNF-? treated epithelial cells and macrophages, and decreases TNF-? induced inflammatory responses in animal lung models.

Please contact us for availability.

Additional information

Three Letter Sequence

H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Ser-Pro-Met-Gly-Val-Asp-His-Met-Ser-Gly-Leu-Ser-Gly-Val-Asn-Val-Pro-Gly-Asn-Ala-Ser-Ser-Gly-OH

Molecular Weight

3696.9

Molecular Formula

C151H257N59O46S2

Sequence

YGRKKRRQRRRSPMGVDHMSGLSGVNVPGNASSG

Solubility

Soluble in water

Appearance

Freeze dried solid

Storage

Store dry, frozen and in the dark

Purity

>95% by HPLC

Searchable Words

TAT-HuR-HNS3, YGRKKRRQRRRSPMGVDHMSGLSGVNVPGNASSG, PP-370, PP370